These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 492550)

  • 1. [New therapeutic prospects in lead poisoning: alpha-mercaptopropionylglycine].
    Franco G; Malamani T; Scalisi L
    Minerva Med; 1979 Sep; 70(41):2811-9. PubMed ID: 492550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chelation in metal intoxication. XXIII: Effect of N-(2-mercaptopropionyl) glycine on lead or lead and ethanol intoxicated rats.
    Tandon SK; Flora SJ
    Biochem Int; 1986 Jun; 12(6):963-8. PubMed ID: 3741452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term therapy of rheumatoid arthritis with alpha-mercaptopropionylglycine].
    Carrozzini B; Selvaggio G
    Minerva Med; 1982 May; 73(19):1301-4. PubMed ID: 6804890
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of changes in certain immunoglobulin fractions in acute and chronic hepatopathies treated with alpha-mercaptopropionylglycine].
    Marinai E; Ulivieri P; Righi A
    Minerva Med; 1977 Dec; 68(62):4193-7. PubMed ID: 600464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of initial results of treatment of lead poisoning with EDTA].
    Petkova V; Adjarov D; Pavlova S; Naydenova E; Kerimova M; Kuneva T
    Med Lav; 1994; 85(4):299-308. PubMed ID: 7808345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment].
    Surrenti C; Arcangeli A; Casini A
    Minerva Med; 1978 Dec; 69(61):4251-6. PubMed ID: 733081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the liver cell clearance fraction before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
    Cortinovis A; Paolini FA; Crippa A
    Arch Sci Med (Torino); 1979; 136(4):497-508. PubMed ID: 550750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the fraction of hepatocyte depuration before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
    Cortinovis A; Paolini FA; Crippa A
    Minerva Med; 1979 Dec; 70(54):3709-13. PubMed ID: 523002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of cysteine calculosis by the continuous administration of alpha-mercaptopropionylglycine].
    Berio A
    Minerva Pediatr; 1983 Dec; 35(23-24):1197-1206. PubMed ID: 6425620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and statistical study of the use of alpha-MPG in the treatment of viral hepatitis].
    Bosio G; Marietti G
    Minerva Med; 1978 May; 69(22):1495-501. PubMed ID: 683551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Thiola in post-hepatitis hepatic insufficiency].
    Precchia G; d'Amico A; Precchia E; Precchia A; Vela R
    Minerva Med; 1977 Jul; 68(36):2505-7. PubMed ID: 887229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine].
    De Pergola E; Carrozzini B; Selvaggio G; De Pergola G
    Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical evaluation of damage due to lead: importance and significance of erythrocyte zinc-protoporhyrin IX and urinary amino acid determination].
    Sanguinetti F; Dompè M; Ronca G
    Ann Ist Super Sanita; 1977; 13(1-2):399-407. PubMed ID: 603137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic therapy of rheumatoid arthritis with thiopronine. Preliminary results].
    Fossaluzza V; Di Benedetto P; Pinat F; Pasqualini M; Massarutto C; Pirrone S; Rossi P; Tosato F; Lucas C; Padovani R
    Minerva Med; 1983 Mar; 74(13):723-6. PubMed ID: 6339997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the changes of some biohumoral parameters related to hepatic function. Special reference to the lipid pattern after treatment with alpha-mercaptopropionylglycine in a group of aged subjects].
    Melga PL; Peluffo F; Ghiorzi GB; Campostano A; Derchi L
    Minerva Med; 1980 Sep; 71(32):2273-80. PubMed ID: 7432659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of 2-mercaptopropionylglycine (MPG) on radiation-induced changes in the acid phosphatase activity of mouse intestine and its role in tissue protection.
    Mathur VB; Uma Devi P; Bisht KS
    Radiobiol Radiother (Berl); 1986; 27(4):479-84. PubMed ID: 3775008
    [No Abstract]   [Full Text] [Related]  

  • 17. 2-mercaptopropionylglycine in the treatment of the hyperviscosity syndrome.
    Triolo L; Magris D; Mian G
    Haematologica; 1980 Feb; 65(1):135. PubMed ID: 6768650
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of clinically normal and cystinuric dogs with 2-mercaptopropionylglycine.
    Hoppe A; Denneberg T; Kågedal B
    Am J Vet Res; 1988 Jun; 49(6):923-8. PubMed ID: 3400930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute and chronic liver disease as well as several malabsorption syndromes with 2 mercaptopropionylglycine MPG (thiola) (author's transl)].
    Markoff NG
    Schweiz Rundsch Med Prax; 1975 Jul; 64(30):958-61. PubMed ID: 1144310
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of cystinuria with Thiola (alpha-mercaptopropionyl glycine).
    Remien A; Kallistratos G; Burchardt P
    Eur Urol; 1975; 1(5):227-8. PubMed ID: 1233187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.